FHLT RSI Chart
Last 7 days
-9.4%
Last 30 days
7.6%
Last 90 days
8.3%
Trailing 12 Months
8.6%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 26, 2024 | bostic bradley | sold | - | - | -2,079,240 | - |
Mar 26, 2024 | future health esg associates 1, llc | sold | - | - | -1,703,490 | - |
Mar 26, 2024 | morgan travis a | sold | - | - | -2,079,240 | - |
Oct 24, 2021 | snyderman nancy lynn md | back to issuer | - | - | -1,689 | - |
Oct 24, 2021 | snyderman nancy lynn md | back to issuer | - | - | -1,688 | - |
Oct 24, 2021 | bostic bradley | back to issuer | - | - | -212,683 | ceo and secretary |
Oct 24, 2021 | future health esg associates 1, llc | back to issuer | - | - | -393,750 | - |
Oct 24, 2021 | mills francis john | back to issuer | - | - | -5,631 | - |
Oct 24, 2021 | mills francis john | back to issuer | - | - | -1,688 | - |
Oct 24, 2021 | morgan travis a | back to issuer | - | - | -184,386 | chief financial officer |
Which funds bought or sold FHLT recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 27, 2024 | NOMURA HOLDINGS INC | unchanged | - | 20.00 | 6,813 | -% |
Mar 01, 2024 | Pineridge Advisors LLC | new | - | 2,305 | 2,305 | -% |
Feb 16, 2024 | Context Capital Management, LLC | unchanged | - | 71,000 | 71,000 | -% |
Feb 14, 2024 | Sculptor Capital LP | unchanged | - | 6.00 | 692 | -% |
Feb 14, 2024 | AQR Arbitrage LLC | unchanged | - | 223 | 3,082 | -% |
Feb 14, 2024 | WHITEBOX ADVISORS LLC | unchanged | - | 150 | 2,062 | -% |
Feb 14, 2024 | Polar Asset Management Partners Inc. | unchanged | - | 96,000 | 8,536,000 | 0.15% |
Feb 14, 2024 | Polar Asset Management Partners Inc. | unchanged | - | 1,596 | 20,604 | -% |
Feb 14, 2024 | TENOR CAPITAL MANAGEMENT Co., L.P. | unchanged | - | 980 | 13,523 | -% |
Feb 14, 2024 | Walleye Trading LLC | unchanged | - | 4,299 | 382,189 | -% |
Unveiling Future Health ESG Corp.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Future Health ESG Corp. News
Balance Sheet | |||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Assets | 0.1% | 17,229 | 17,215 | 17,086 | 17,298 | 17,258 | 202,874 | 202,290 | 202,373 | 202,633 | 202,764 |
Current Assets | -57.9% | 127 | 302 | 386 | 792 | 927 | 803 | 1,100 | 1,299 | 1,555 | 1,661 |
Cash Equivalents | -53.6% | 120 | 258 | 321 | 679 | 838 | 605 | 962 | 1,130 | 1,446 | 1,548 |
Liabilities | 70.0% | 17,441 | 10,262 | 10,200 | 10,458 | 10,315 | 9,942 | 9,457 | 9,016 | 9,124 | 9,109 |
Current Liabilities | 568.8% | 8,441 | 1,262 | 1,200 | 1,458 | 1,315 | 1,212 | 759 | 16.00 | 124 | 109 |
Shareholder's Equity | -Infinity% | -10,277 | - | - | - | -9,388 | - | - | - | -7,490 | - |
Retained Earnings | -3.2% | -10,278 | -9,960 | -9,814 | -9,667 | -9,388 | -8,634 | -8,330 | -7,643 | -7,490 | -7,345 |
Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding | - | - | - | 5,000 | 6,592 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,750 |
Float | - | - | - | 16,361 | - | - | - | 247,250 | - | 195,000 | - |
Cashflow (Quarterly) | |||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 |
Cashflow From Operations | -120.0% | -138 | -62.77 | -358 | -158 | -272 | -357 | -310 | -316 | -75.19 | 17.00 | -185 | - |
Cashflow From Investing | - | - | - | - | - | 187,132 | - | - | - | - | - | - | - |
Cashflow From Financing | - | - | - | - | - | -389,316 | - | - | - | -26.56 | 202,505 | 212 | - |
STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
General and administrative expenses | $ 627,731 | $ 2,206,911 |
Franchise tax expense | 50,860 | 200,531 |
Loss from operations | (678,591) | (2,407,442) |
Other income: | ||
Interest income on cash balance | 13,472 | 10,332 |
Gain on marketable securities, dividends and interest, held in Trust Account | (770,686) | (2,601,727) |
Income before income taxes | 105,567 | 204,617 |
Provision for income taxes | (153,992) | (144,810) |
Net (loss) income | $ (48,425) | $ 59,807 |
Common stock subject to possible redemption | ||
Other income: | ||
Weighted average shares outstanding, basic (in shares) | 1,587,947 | 19,193,054 |
Weighted average shares outstanding, diluted (in shares) | 1,587,947 | 19,193,054 |
Basic net income (loss) per share (in dollars per share) | $ (0.01) | $ 0.00 |
Diluted net income (loss) per share (in dollars per share) | $ (0.01) | $ 0.00 |
Non-redeemable common stock | ||
Other income: | ||
Weighted average shares outstanding, basic (in shares) | 5,000,000 | 5,000,000 |
Weighted average shares outstanding, diluted (in shares) | 5,000,000 | 5,000,000 |
Basic net income (loss) per share (in dollars per share) | $ (0.01) | $ 0.00 |
Diluted net income (loss) per share (in dollars per share) | $ (0.01) | $ 0.00 |
BALANCE SHEETS - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash | $ 119,745 | $ 837,692 |
Prepaid expenses | 7,500 | 89,446 |
Total current assets | 127,245 | 927,138 |
Marketable securities held in Trust Account | 17,101,935 | 16,331,249 |
Total Assets | 17,229,180 | 17,258,387 |
Current liabilities: | ||
Accrued expenses and accounts payable | 1,174,498 | 1,050,386 |
Redeemed stock payable to stockholders | 7,035,905 | |
Excise tax payable | 70,359 | |
Franchise and income taxes payable | 159,965 | 264,859 |
Total current liabilities | 8,440,727 | 1,315,245 |
Deferred underwriting and advisory fees payable | 9,000,000 | 9,000,000 |
Total liabilities | 17,440,727 | 10,315,245 |
Commitments and Contingencies (Note 5): | ||
Common stock subject to possible redemption; 936,447 and 1,591,537 shares issued and outstanding at redemption value of $10.75 and $10.26 per share as of December 31, 2023 and 2022, respectively | 10,066,030 | 16,331,249 |
Stockholders' Deficit: | ||
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding | ||
Common stock, $0.0001 par value; 26,000,000 and 500,000,000 shares authorized as of December 31, 2023 and 2022, respectively; 5,000,000 shares issued and outstanding | 500 | 500 |
Accumulated deficit | (10,278,077) | (9,388,607) |
Total stockholders' deficit | (10,277,577) | (9,388,107) |
Total Liabilities, Common Stock Subject to Possible Redemption, and Stockholders' Deficit | $ 17,229,180 | $ 17,258,387 |